風範股份(601700.SH):上海瑞力新興產業投資基金擬進行清算
格隆匯7月1日丨風範股份(601700.SH)公佈,第六屆董事會第十四次會議,審議通過了《關於上海瑞力新興產業投資基金(有限合夥)清算的議案》,同意對上海瑞力新興產業投資基金(有限合夥)進行清算。本事項尚需提交股東會審議。公司參與設立的上海瑞力新興產業投資基金(有限合夥)(簡稱“瑞力基金”)存續期限將於2025年7月8日期滿。根據《中華人民共和國合夥企業法》及《上海瑞力新興產業投資基金(有限合夥)有限合夥協議》的有關規定,瑞力基金普通合夥人上海瑞久投資管理合夥企業(有限合夥)擬作爲基金的清算人,將對瑞力基金進行清算。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.